Our Experience
Our team brings vast experience and a track record of timely and efficient delivery of Phase I through IV studies.
Since its inception in 2012, Red Maple Trials has completed
42
Clinical trials
12
Internal research projects
56
Publications
Study focus areas
-
Seasonal Allergic Rhinitis (SAR)
-
Perennial Allergic Rhinitis (PAR)
-
Cat Allergy
-
COVID-19 Vaccine
-
Influenza Vaccine
-
Infectious Diseases
-
Medical Devices
-
Allergic Conjunctivitis
-
Asthma
Our leadership
Our team has held various leadership positions in associations, societies, and industry advisory boards, including Vice-President Board of Journals, Board Member of Research Consortiums, Consulting Staff at The Ottawa Hospital, and Clinical Assistant Professor at local universities.
As a team, we bring decades of experience from across the clinical, academic, research and regulatory spectrum. Our international reputation has seen us working with partners throughout North America, Europe, and Asia, as well as presenting at various international conferences around the globe.
We supplement our specialized expertise with strong business, strategy, and operations practitioners who bring decades of experience, having worked at leading global consulting firms and having advised senior management and executives in hospitals, agencies, the private sector, and government.